“COMPARISON OF MEAN GLYCATED HEMOGLOBIN (HBA1C) IN TYPE 2 DIABETIC HEPATITIS C (HCV) PATIENTS WITH SVR ACHIEVED VERSUS SVR NOT ACHIEVED FOLLOWING DIRECT ACTING ANTIVIRALS (DAAS) THERAPY” (2025) The Research of Medical Science Review, 3(6), pp. 94–100. Available at: https://medscireview.net/index.php/Journal/article/view/1284 (Accessed: 6 August 2025).